Changes in lung function pre- and post-antibiotics
| All patients (n=26) | p Values | Positive Aspergillus PCR (n=20) | p Values | Negative Aspergillus PCR (n=6) | p Values | ||||
|---|---|---|---|---|---|---|---|---|---|
| Pre-antibiotics | Post-antibiotics | Pre-antibiotics | Post-antibiotics | Pre-antibiotics | Post-antibiotics | ||||
| FEV1% predicted | 30 (22–36) | 36 (26–50) | <0.001 | 33 (25–38) | 39 (30–51) | <0.001 | 22 (21–33) | 24 (22–43) | 0.07 |
| FVC % predicted | 49 (35–59) | 59 (44–69) | <0.001 | 52 (36–60) | 63 (49–70) | <0.001 | 35 (31–47) | 41 (36–64) | 0.03 |
Values are shown as median (IQR).
Changes in lung function were measured using Wilcoxon signed rank tests.
FEV1, forced expiratory volume in 1 s; FVC, forced vital capacity.